tradmap

TWST Twist Bioscience Corp

$128.68 -1.77%

Updated

Healthcare · Biological Products, (No Diagnostic Substances)

Twist Bioscience Corp (TWST) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry, with a market capitalization of $8.1 billion. Shares last traded at $128.68, 17.2% below their 52-week high. Over the past year the stock is up 395.3%. Net profit margin is -31.7%, below the peer median of 5.3%. Revenue grew 20.3% year over year.

Market Cap
$8.1B
Shares Out
62.7M
EPS (TTM)
$-4.34
P/E Ratio
P/S Ratio
18.69
P/B Ratio
18.10
Dividend / Share
Dividend Yield
52-Week High
$155.43
52-Week Low
$23.42
Volume
65,617
Avg Vol (3m)
106,714.444

Performance

1W
-15.98%
1M
+11.89%
3M
+74.17%
6M
+164.45%
YTD
+297.22%
1Y
+395.30%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
51.87
SMA (50)
$110.34
SMA (200)
$64.26
Price vs SMA50
+16.63%
Price vs SMA200
+100.24%
ATR (14)
$8.82

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$432M
Net Income
$-137M
Gross Margin
52.0%
Operating Margin
-33.6%
Net Margin
-31.7%
Return on Equity
-30.7%
Return on Assets
-20.3%
Current Ratio
2.67
Debt / Equity
0.00
Revenue Growth (YoY)
+20.3%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 $-1.78 2026-08-03
Q2 2026 $-1.21 2026-05-04
Q1 2026 $-0.50 2026-02-02
FY 2025 $-1.30 2025-11-17
Q3 2026 $-0.85 2026-08-03
Q2 2026 $-1.19 2026-05-04

Full earnings history →

Biological Products, (No Diagnostic Substances) peers

TWST vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap. Updated

P/S vs peers
18.69 / 19.49 med
-4% discount
Net margin vs peers
-31.7% / 5.3% med
below median
1–14 of 14
AMGNAmgen$240.1B27.476.3023.0%+0.31%
GILDGilead Sciences$187.5B-57.876.16-10.6%+1.09%
MRNAModerna$58.8B-18.68-1.94%
RVMDRevolution Medicines, Inc.$45.2B-25.55+0.76%
BIIBBiogen$33.1B24.163.3413.8%+0.78%
NBIXNeurocrine Biosciences Inc$16.1B22.814.7720.9%+0.33%
EXELExelixis, Inc.$14.7B17.036.0235.3%+1.00%
HALOHalozyme Therapeutics, Inc.$12.6B30.397.5524.9%+1.01%
TECHBio-Techne$11.4B62.489.3515.0%+0.21%
KRYSKrystal Biotech, Inc.$11.0B45.5224.9554.8%+0.58%
APGEApogee Therapeutics, Inc.$10.2B-34.57+0.04%
KYMRKymera Therapeutics, Inc.$9.7B-32.51-1.24%
RGENRepligen Corp$9.6B230.5312.205.3%-1.87%
PCVXVaxcyte, Inc.$9.1B-8.56-0.62%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.